Bayer (BAYRY)
(Delayed Data from OTC)
$7.39 USD
+0.12 (1.65%)
Updated Apr 26, 2024 03:59 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Income Statements
Fiscal Year end for Bayer Aktiengesellschaft falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 51,558 | 53,459 | 52,152 | 47,291 | 48,770 |
Cost Of Goods | 21,374 | 20,936 | 19,895 | 21,861 | 19,563 |
Gross Profit | 30,183 | 32,523 | 32,257 | 25,430 | 29,207 |
Selling & Adminstrative & Depr. & Amort Expenses | 29,521 | 25,135 | 28,290 | 43,900 | 24,516 |
Income After Depreciation & Amortization | 662 | 7,388 | 3,967 | -18,470 | 4,692 |
Non-Operating Income | 475 | 316 | 680 | 901 | 711 |
Interest Expense | 2,892 | 2,784 | 2,227 | 2,136 | 2,177 |
Pretax Income | -1,754 | 4,920 | 2,421 | -19,705 | 3,226 |
Income Taxes | 1,430 | 531 | 1,211 | -1,929 | 504 |
Minority Interest | -1 | 17 | 26 | 9 | 21 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -3,184 | 4,389 | 1,209 | -17,775 | 2,722 |
Extras & Discontinued Operations | 0 | 0 | 0 | 5,796 | 1,882 |
Net Income (GAAP) | -3,183 | 4,372 | 1,183 | -11,988 | 4,582 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11,507 | 14,239 | 7,582 | -3,324 | 10,700 |
Depreciation & Amortization (Cash Flow) | 10,845 | 6,852 | 3,616 | 15,146 | 6,009 |
Income After Depreciation & Amortization | 662 | 7,388 | 3,967 | -18,470 | 4,692 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3,934.45 | 3,933.65 | 3,929.68 | 3,929.68 | 3,924.22 |
Diluted EPS Before Non-Recurring Items | 1.73 | 2.09 | 1.93 | 1.82 | 1.77 |
Diluted Net EPS (GAAP) | -0.81 | 1.11 | 0.30 | -3.05 | 1.17 |
Fiscal Year end for Bayer Aktiengesellschaft falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 12,813.76 | 11,256.23 | 12,042.38 | 15,445.15 |
Cost Of Goods | NA | 4,838.65 | 5,237.38 | 5,144.51 | 6,153.80 |
Gross Profit | NA | 7,975.11 | 6,018.85 | 6,897.87 | 9,291.35 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5,549.82 | 9,930.57 | 7,940.29 | 6,100.13 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,425.29 | -3,911.72 | -1,042.42 | 3,191.22 |
Non-Operating Income | NA | 225.34 | 111.02 | 19.63 | 119.15 |
Interest Expense | NA | 809.16 | 876.16 | 693.49 | 513.09 |
Pretax Income | NA | 1,841.46 | -4,676.86 | -1,716.29 | 2,797.28 |
Income Taxes | NA | 326.37 | 304.75 | 343.48 | 455.12 |
Minority Interest | NA | 5.51 | -8.71 | -2.18 | 4.29 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,515.09 | -4,981.61 | -2,059.77 | 2,342.16 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,509.58 | -4,972.90 | -2,057.59 | 2,337.87 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 3,932.35 | 3,921.89 | 3,931.25 | 3,924.32 |
Diluted EPS Before Non-Recurring Items | NA | 0.50 | 0.10 | 0.33 | 0.79 |
Diluted Net EPS (GAAP) | NA | 0.39 | -1.27 | -0.52 | 0.60 |